Effect of vitamin Dâ‚ƒ and two low-calcemic vitamin Dâ‚ƒ analogues on osteopontin (OPN) - mediated neoplastic transformation

Effect of vitamin Dâ‚ƒ and two low-calcemic vitamin Dâ‚ƒ analogues on osteopontin (OPN) - mediated neoplastic transformation

Bibliographic Details
Main Author:	McCann, Mella Elizabeth
Published:	Queen's University Belfast 2005
Subjects:	616.9940610724
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.426690

Similar Items

Phenolic stilbene analogues and their chemical oxidation products as new antitumour agents
by: Lion, Cedric J.
Published: (2005)

Synthetic approaches to the marine natural products eleutherobin (and analogues) and norcembranolide I
by: O'Connell, Ciara
Published: (2006)

Developing a cancer model in Zebrafish suitable for forward chemical genetic screening
by: Jones, Mary Elizabeth
Published: (2008)

Identification and characterisation of proteins interacting with eukaryotic topoisomerase II
by: Barker, Catherine Rachel
Published: (2004)

AQ4N : evaluation and enhancement of its role as an anti-tumour agent
by: Ward, Claire
Published: (2005)

Statistical approaches to interim analysis a critical approach
by: Floriani, Irene Claudia
Published: (2005)

Catalytic processes in anti-cancer drug discovery
by: Inman, Martyn William
Published: (2008)

Development of novel mouse models to study the p53 tumour suppressor
by: Crawford, Kerryanne
Published: (2013)

Redirecting dendritic cells and macrophages towards tumour rejection
by: Guiducci, Cristiana
Published: (2005)

Towards the synthesis of novel upper rim calixsugars
by: Payerne, Estelle
Published: (2008)

Synthesis of novel compounds for evaluation of anti-cancer activity
by: Ferguson, Jillian
Published: (2005)

Mechanisms of tumour escape following intratumour therapy with DISC-HSV in a murine model
by: Ahmad, Murrium
Published: (2004)

Early response assessment in oncology
by: Maisey, Nicholas Robert
Published: (2003)

A microarray approach to identification of the target of a novel class of quinazoline-based anti-tumour agent
by: Barry, Allan
Published: (2004)

A means to an end? : a study of patients' experiences of participation in phase I and II anti-cancer drug trials
by: Cox, Karen
Published: (1999)

Investigation into the mechanism of action of G-quadruplex interacting telomerase inhibitors
by: Incles, Christopher Mark
Published: (2003)

Biological and biophysical studies of polycyclic acridines as novel telomerase inhibitors
by: Cheng, Mai-Kim
Published: (2005)

Pre-clinical pharmacology and cancer chemopreventive activity of indole-3-carbinol and 3,3'-diindolylmethane
by: Anderton, Mark John
Published: (2004)

Modulation of chemotherapy by inhibition of the epidermal growth factor receptor
by: Friedmann, Benjamin Jacob
Published: (2006)

Computational studies of DNA structure and recognition
by: Grindon, Christina Rebecca
Published: (2004)

An investigation of the effects of selected Chinese herbal remedies on cancer cells 'in vitro'
by: Willimott, Shaun
Published: (2007)

Isolation and characterization of a novel repressor (S) of osteopontin (OPN)-mediated neoplastic transformation
by: Jin, Dachan
Published: (2006)

The Response of Creatine Kinase Specific Activity in Rat Pituitary to Estrogenic Compounds and Vitamin D Less-Calcemic Analogs
by: D. Somjen, et al.
Published: (2009-01-01)

The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease.
by: Jürgen Glas, et al.
Published: (2011-01-01)

The causal effect of vitamin D binding protein (DBP) levels on calcemic and cardiometabolic diseases: a Mendelian randomization study.
by: Aaron Leong, et al.
Published: (2014-10-01)

Antiproliferative Activity of Non-Calcemic Vitamin D Analogs on Human Melanoma Lines in Relation to VDR and PDIA3 Receptors
by: Tomasz Wasiewicz, et al.
Published: (2018-08-01)

The Effect of Osteopontin (OPN) and miR196a in Diabetic Nephropathy (DN)
by: Pai, Chiao-Chih, et al.
Published: (2017)

Osteopontin Gene Polymorphism and Urinary OPN Excretion in Patients with Immunoglobulin A Nephropathy
by: Beata Kaleta, et al.
Published: (2019-05-01)

Curcumin Veto the Effects of Osteopontin (OPN) Specific Inhibitor on Leukemic Stem Cell Colony Forming Potential via Promotion of OPN Overexpression
by: Saeed Mohammadi, et al.
Published: (2016-06-01)

Vitamin D3-induced calcemic and phosphatemic responses in the freshwater mud eel Amphipnous cuchia maintained in different calcium environments
by: Ajai K. Srivastav, et al.
Published: (1997-11-01)

The role of vitamin D in dogs with Spirocerca lupi-associated neoplastic transformation
by: Rosa, Chantal Teixeira
Published: (2016)

Osteopontin (OPN) is an important protein to mediate improvements in the biocompatibility of C ion-implanted silicone rubber.
by: Shao-liang Wang, et al.
Published: (2014-01-01)

Vitamin D and the vitamin D receptor in breast cancer
by: Lowe, Lorraine Claire
Published: (2006)

Tcf-4 regulates osteopontin-mediated malignant transformation in human breast cancer
by: Ravindranath, Amod
Published: (2010)

Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.
by: Elmira Agah, et al.
Published: (2018-01-01)

Neoplastic transformation and ageing of submandibular gland epithelial cells in vivo and in vitro
by: Knowles, M. A.
Published: (1977)

Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity.
by: Andrzej T Slominski, et al.
Published: (2010-03-01)

Identification of early biomarkers of neoplastic transformation in mouse tumour models of breast carcinogenesis
by: Tomirotti, Andrea Massimiliano
Published: (2016)

The effect of age on neoplastic transformation of adult mouse bladder epithelium : an in vivo and in vitro study
by: Summerhayes, I. C.
Published: (1978)

Vitamin D and breast cancer
by: Brosseau, Carole
Published: (2010)